What is the expected growth forecast for the Human Immunodeficiency Virus Testing market?

The market is expected to grow at a CAGR of 6.2% from 2023 to 2028, driven by increasing demand.

What are the key drivers of the Human Immunodeficiency Virus Testing market?

Key drivers include rising awareness, government initiatives, and advancements in diagnostic technologies.

What are the major challenges facing the Human Immunodeficiency Virus Testing market?

Challenges include high costs, limited access to testing in remote areas, and social stigma.

Which regions are leading the Human Immunodeficiency Virus Testing market?

North America and Europe are leading, due to high awareness and advanced healthcare infrastructure.

Who are the top companies in the Human Immunodeficiency Virus Testing market?

Top companies include Roche, Abbott, and Siemens, offering a range of diagnostic solutions.

What future opportunities exist in the Human Immunodeficiency Virus Testing market?

Opportunities include emerging markets, point-of-care testing, and home-based testing kits.

How is technology impacting the Human Immunodeficiency Virus Testing market?

Technology is improving diagnostic accuracy, speed, and accessibility, with advancements in molecular diagnostics.

What is the current regulatory landscape for the Human Immunodeficiency Virus Testing market?

The regulatory landscape is evolving, with a focus on ensuring test accuracy, safety, and accessibility.

What is the future outlook for the Human Immunodeficiency Virus Testing market?

The future outlook is positive, driven by increasing demand, advancements in technology, and expanding access to testing.

How Big Is the Human Immunodeficiency Virus Testing Market? Size, Share & Forecast 2033

Human Immunodeficiency Virus Testing by Application (Diagnostic Centers, Hospitals, Home Use), by Types (Antibody Tests, RNA (viral load) Test, Antibody-antigen Test), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Human Immunodeficiency Virus Testing Market Size | CAGR 8.1 Forecast 2033

How Big Is the Human Immunodeficiency Virus Testing Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 8.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Human Immunodeficiency Virus Testing Market Overview

The Human Immunodeficiency Virus (HIV) Testing market refers to the industry involved in the development, manufacturing, and distribution of products and services for detecting HIV infection. As the Human Immunodeficiency Virus Testing market size is expected to grow significantly, driven by increasing awareness and advancements in diagnostic technologies, understanding the growth outlook, market forecast, and industry expansion is crucial for stakeholders. The scope of this market encompasses various HIV testing methods, including nucleic acid tests, enzyme-linked immunosorbent assay (ELISA), and rapid tests, catering to different end-users such as hospitals, clinics, and research institutions. According to recent data, the current Human Immunodeficiency Virus Testing market size is approximately $3.3 billion. The market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 8.5% from 2026 to 2033, driven by macro drivers such as increasing prevalence of HIV, advancements in technology, and government initiatives.

Loading chart…

Key forces shaping the HIV Testing industry include technology shifts towards more accurate and rapid testing methods, regulations supporting the use of advanced diagnostic technologies, and consumer behavior driving the demand for convenient and non-invasive testing solutions. The largest region in the Human Immunodeficiency Virus Testing market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing awareness and government initiatives. As the market continues to evolve, understanding these dynamics is essential for strategic planners, business development teams, and C-suite executives to make informed decisions and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	23.50 million
Growth rate	CAGR of 8.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Abbott; Bio-Rad; WanTai BioPharm; Beckman Coulter; BD; Kehua; Livzon; Intec; ThermoFisher; Biokit; Nectar Lifesciences; ELITech Group; Chembio Diagnostic Systems; Trinity Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Human Immunodeficiency Virus Testing market is poised for significant growth, driven by increasing awareness and advances in testing technologies. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape.

Growth Drivers2 items

Advancements in point-of-care testing technologies have improved the accessibility and efficiency of Human Immunodeficiency Virus Testing, contributing to the growth of the Human Immunodeficiency Virus Testing market size. This shift is expected to influence the growth forecast, with the market anticipated to expand rapidly in the coming years.

Government initiatives and public-private partnerships aimed at increasing awareness and promoting early detection have fueled the demand for Human Immunodeficiency Virus Testing, further propelling the market's growth trajectory.

Restraints2 items

The high cost of certain Human Immunodeficiency Virus Testing kits, particularly those utilizing advanced technologies, can limit adoption in low-resource settings, acting as a restraint on the overall Human Immunodeficiency Virus Testing market size.

Stringent regulatory requirements for the approval of new testing kits can hinder the entry of new players into the market, potentially slowing the growth forecast of the Human Immunodeficiency Virus Testing market.

Opportunities2 items

The integration of artificial intelligence and machine learning in Human Immunodeficiency Virus Testing could enhance diagnostic accuracy and efficiency, presenting significant opportunities for innovation and growth within the Human Immunodeficiency Virus Testing market.

Expanding testing services into rural and underserved areas, through mobile testing units or community-based initiatives, can help tap into unmet demand and further increase the Human Immunodeficiency Virus Testing market size.

Challenges2 items

Ensuring the privacy and confidentiality of patient data, particularly in the context of Human Immunodeficiency Virus Testing, poses a significant challenge that must be addressed through robust data protection measures.

The global supply chain for Human Immunodeficiency Virus Testing kits and reagents can be vulnerable to disruptions, affecting the reliability of testing services and impacting the overall growth forecast of the Human Immunodeficiency Virus Testing market.

Market Segmentation

Loading chart…

The Human Immunodeficiency Virus Testing segmentation by application refers to the categorization of the market based on the purpose or use of the testing products. This includes diagnostic testing, blood screening, and recipient testing. Each application contributes to the overall Human Immunodeficiency Virus Testing market size, with diagnostic testing being the largest segment. The application segment is crucial in understanding the market taxonomy and identifying opportunities for growth.

The Human Immunodeficiency Virus Testing market can be segmented by types, including ELISA, rapid tests, Western Blot, and PCR. These types are sub-categorized into further subtypes, such as [object Object] and [object Object]. The types segment is significant in determining the market size, as each type has its own set of applications and end-users. Understanding the types of Human Immunodeficiency Virus Testing products is essential for market players to develop targeted strategies and products.

Human Immunodeficiency Virus Testing Segmentation Breakdown8 items

Application

Diagnostic Centers

Hospitals

Home Use

Types

Antibody Tests

RNA (viral load) Test

Antibody-antigen Test

Regional Insights

Loading chart…

The Human Immunodeficiency Virus Testing market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the global market, and Latin America being the fastest-growing region. Key drivers for North America include increasing adoption of point-of-care testing, government policies supporting HIV awareness, and significant investments in research and development. In Europe, factors such as a mature ecosystem, high infrastructure development, and a large demographics base contribute to market growth.

In Asia Pacific, the growing infrastructure and increasing adoption of advanced diagnostic technologies drive the Human Immunodeficiency Virus Testing market. Latin America benefits from government initiatives to improve policies and investments in healthcare infrastructure. The Middle East & Africa region is expected to experience steady growth due to increasing awareness and ecosystem maturity. Understanding these regional dynamics is crucial for a comprehensive regional forecast.

Competitive Landscape

The Human Immunodeficiency Virus Testing market is moderately consolidated, driven by a mix of global players and local/regional companies. The Human Immunodeficiency Virus Testing competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize pricing and distribution.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players implement strategies to stay competitive, as outlined below:

Roche: regional expansion

Abbott: innovation pipeline

Bio-Rad: premium pricing

WanTai BioPharm: local manufacturing

Beckman Coulter: vertical integration

BD: OEM tie-ups

Key Human Immunodeficiency Virus Testing Companies15 items

Roche

Abbott

Bio-Rad

WanTai BioPharm

Beckman Coulter

Kehua

Livzon

Intec

ThermoFisher

Biokit

Nectar Lifesciences

ELITech Group

Chembio Diagnostic Systems

Trinity Biotech

Market Ecosystem

The Human Immunodeficiency Virus Testing ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers develop testing solutions; and downstream, where channels and end users interact. The value chain analysis of this ecosystem reveals how value is created and captured through the development, distribution, and utilization of HIV testing products and services.

Raw material/component suppliers — provide critical reagents and equipment

Technology providers — develop innovative testing technologies

OEMs / manufacturers — produce HIV testing kits and devices

Distributors / channel partners — facilitate the delivery of testing products

Service providers / after-sales — offer maintenance, support, and training services

Regulators/standards bodies — establish guidelines and approval frameworks

End users / buyers — healthcare providers, laboratories, and patients

The flow of value within the Human Immunodeficiency Virus Testing ecosystem is influenced by various control points, including regulatory approvals, technology adoption, and partnerships between participants. Dependency risks, such as input constraints and standards compliance, can impact the ecosystem's efficiency. Furthermore, switching costs, interoperability requirements, and regional differences in healthcare infrastructure and regulations can affect the ecosystem's dynamics, leading to variations in how value is created and captured across different regions.

Recent Industry Insights

The Human Immunodeficiency Virus Testing industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between pharmaceutical companies and research institutions, have accelerated the development of innovative testing technologies. Additionally, mergers and acquisitions have led to the expansion of product portfolios and the strengthening of market positions. The launch of new products and technologies, including point-of-care diagnostic kits and molecular tests, has improved the accessibility and accuracy of HIV testing.

The industry has also seen notable regulatory changes, with updated guidelines for HIV testing and diagnosis. Furthermore, there has been a shift in consumer trends, with an increasing demand for self-testing and home-based testing solutions. Funding rounds and expansions have also been observed, with investments in research and development aimed at improving testing technologies and increasing their availability in resource-limited settings. These developments are expected to drive the growth of the Human Immunodeficiency Virus Testing market in the coming years.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view of the Human Immunodeficiency Virus Testing market outlook. The market attractiveness is moderate, driven by increasing awareness and government initiatives. Competitive intensity is high, with key players focusing on innovative technologies to improve testing accuracy and efficiency.

The long-term outlook for the Human Immunodeficiency Virus Testing market is positive, with a growing demand for point-of-care testing and home-based testing kits. The innovation landscape is evolving, with emerging technologies such as rapid testing and mobile health solutions. However, demand-supply balance and key risk factors such as regulatory changes and supply chain disruptions need to be closely monitored to ensure sustainable growth.

11 items

1. Executive Summary

2. Human Immunodeficiency Virus Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Human Immunodeficiency Virus Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Human Immunodeficiency Virus Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Diagnostic Centers

6.1.2. Hospitals

6.1.3. Home Use

6.2. Global Human Immunodeficiency Virus Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Antibody Tests

6.2.2. RNA (viral load) Test

6.2.3. Antibody-antigen Test

6.3. Global Human Immunodeficiency Virus Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Human Immunodeficiency Virus Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Human Immunodeficiency Virus Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Human Immunodeficiency Virus Testing Market Competition by Key Manufacturers

8.1. Global Human Immunodeficiency Virus Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Human Immunodeficiency Virus Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Roche

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bio-Rad

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. WanTai BioPharm

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Beckman Coulter

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BD

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Kehua

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Livzon

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Intec

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. ThermoFisher

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Biokit

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Nectar Lifesciences

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. ELITech Group

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Chembio Diagnostic Systems

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Trinity Biotech

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Human Immunodeficiency Virus Testing Market

Figure 4: Global Human Immunodeficiency Virus Testing Market: Drivers

Figure 5: Global Human Immunodeficiency Virus Testing Market: Challenges

Figure 6: Global Human Immunodeficiency Virus Testing Market: Trends

Figure 7: Global Human Immunodeficiency Virus Testing Market: Opportunity

Figure 8: Global Human Immunodeficiency Virus Testing Market: Restraint

Figure 9: Global Human Immunodeficiency Virus Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Human Immunodeficiency Virus Testing Market Value (USD Million) By Region

Figure 15: Global Human Immunodeficiency Virus Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Human Immunodeficiency Virus Testing Market Value (USD Million) By Region

Figure 23: Global Human Immunodeficiency Virus Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Human Immunodeficiency Virus Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Human Immunodeficiency Virus Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Human Immunodeficiency Virus Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Human Immunodeficiency Virus Testing Market Value (USD Million) By Region

Table 10: Global Human Immunodeficiency Virus Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Human Immunodeficiency Virus Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Human Immunodeficiency Virus Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Human Immunodeficiency Virus Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Roche Basic Information And Sales Area

Table 31: Roche. Products Portfolio

Table 32: Abbott Basic Information And Sales Area

Table 33: Abbott. Products Portfolio

Table 34: Bio-Rad Basic Information And Sales Area

Table 35: Bio-Rad. Products Portfolio

Table 36: WanTai BioPharm Basic Information And Sales Area

Table 37: WanTai BioPharm. Products Portfolio

Table 38: Beckman Coulter Basic Information And Sales Area

Table 39: Beckman Coulter. Products Portfolio

Table 40: BD Basic Information And Sales Area

Table 41: BD. Products Portfolio

Table 42: Kehua Basic Information And Sales Area

Table 43: Kehua. Products Portfolio

Table 44: Livzon Basic Information And Sales Area

Table 45: Livzon. Products Portfolio

Table 46: Intec Basic Information And Sales Area

Table 47: Intec. Products Portfolio

Table 48: ThermoFisher Basic Information And Sales Area

Table 49: ThermoFisher. Products Portfolio

Table 50: Biokit Basic Information And Sales Area

Table 51: Biokit. Products Portfolio

Table 52: Nectar Lifesciences Basic Information And Sales Area

Table 53: Nectar Lifesciences. Products Portfolio

Table 54: ELITech Group Basic Information And Sales Area

Table 55: ELITech Group. Products Portfolio

Table 56: Chembio Diagnostic Systems Basic Information And Sales Area

Table 57: Chembio Diagnostic Systems. Products Portfolio

Table 58: Trinity Biotech Basic Information And Sales Area

Table 59: Trinity Biotech. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Human Immunodeficiency Virus Testing Market Value (USD Million) By Region

Table 65: Global Human Immunodeficiency Virus Testing Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Human Immunodeficiency Virus Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	23.50 million
Growth rate	CAGR of 8.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Abbott; Bio-Rad; WanTai BioPharm; Beckman Coulter; BD; Kehua; Livzon; Intec; ThermoFisher; Biokit; Nectar Lifesciences; ELITech Group; Chembio Diagnostic Systems; Trinity Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options